TL;DR: The Centers for Medicare & Medicaid Services modified NCD 354 governing TENS coverage for chronic low back pain, effective February 11, 2026. Here's what billing teams need to know before submitting claims.
CMS TENS coverage policy under NCD 354 Medicare is narrow by design — and it's been narrow since 2012. This update reaffirms that coverage for Transcutaneous Electrical Nerve Stimulation for chronic low back pain only applies under Coverage with Evidence Development (CED). Your patient must be enrolled in an approved clinical study. If they're not, the claim gets denied. Full stop.
This matters because TENS for CLBP is a common clinical request, and the gap between what patients and providers expect and what Medicare actually covers is wide. If your TENS billing workflow doesn't already screen for CED enrollment, this policy is costing you money in denials right now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back Pain |
| Policy Code | NCD 354 |
| Change Type | Modified |
| Effective Date | February 11, 2026 |
| Impact Level | High |
| Specialties Affected | Pain management, physical medicine & rehabilitation, neurology, primary care, DME suppliers |
| Key Action | Verify CED clinical trial enrollment before billing TENS for any chronic low back pain diagnosis |
CMS TENS Coverage Criteria and Medical Necessity Requirements 2026
NCD 354 is the National Coverage Determination governing Medicare coverage of TENS for chronic low back pain. CMS defines CLBP precisely, and that definition matters for medical necessity determinations.
To qualify as CLBP under this coverage policy, the patient must meet two conditions. First, the episode of low back pain must have persisted for three months or longer. Second, the pain must not be a manifestation of a clearly defined primary disease entity.
That second criterion trips up a lot of billing teams. If your patient's low back pain stems from spinal metastases, rheumatoid arthritis, or multiple sclerosis, CMS does not consider that CLBP under NCD 354. Those are primary disease manifestations — excluded by definition. Document the distinction clearly in the medical record.
Coverage Is CED-Only — No Exceptions
CMS covers TENS for CLBP only under Coverage with Evidence Development, under section 1862(a)(1)(E) of the Social Security Act. CED means the patient must be enrolled in an approved randomized controlled clinical study. There is no pathway to standard coverage outside of that enrollment.
The approved studies must address at least one of three research questions: whether TENS provides clinically meaningful pain reduction in Medicare beneficiaries with CLBP, whether it improves function, or whether it changes utilization of other medical treatments for CLBP.
The study design requirements are rigorous. Studies must be randomized and controlled, use validated and reliable instruments, and include either sham (placebo) TENS or active TENS in control and comparison groups. Randomized crossover designs are allowed, but only when the protocol accounts for the impact of prior TENS use.
Prior Authorization and Reimbursement Context
This policy does not explicitly list prior authorization requirements in the NCD text. However, because TENS devices for home use bill under the durable medical equipment benefit, your Medicare Administrative Contractor may have additional prior auth requirements at the local level. Check your MAC's local coverage determination policies before assuming the NCD alone governs the claim.
TENS reimbursement under Medicare runs through the DME fee schedule. The device itself is billed as durable medical equipment. If your team is billing TENS for CLBP without confirming CED enrollment first, you're billing outside covered indications — and that's a claim denial waiting to happen.
CMS TENS Exclusions and Non-Covered Indications
CMS is explicit: TENS for CLBP is not covered as a standard benefit. The only covered pathway is CED enrollment. Any claim for TENS for chronic low back pain outside an approved clinical study is non-covered under this policy.
There are also diagnostic exclusions built into the CLBP definition. Low back pain that is a symptom of metastatic cancer, a recognized systemic disease (like rheumatoid arthritis or multiple sclerosis), or any other clearly defined primary diagnosis does not qualify as CLBP under NCD 354. Those patients fall outside this coverage policy entirely.
The three-year CED coverage window is worth flagging separately. The original 2012 decision noted that CED coverage expires three years after publication. The February 11, 2026 modification resets the clock on this policy, but your compliance officer should confirm the precise coverage window associated with each approved clinical study your patients enroll in.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| CLBP (≥3 months, no primary disease entity) — patient enrolled in approved CED clinical study | Covered (CED only) | Bill under DME benefit | Patient must be in an approved randomized controlled study meeting all NCD 354 study requirements |
| CLBP — patient NOT enrolled in approved CED study | Not Covered | N/A | No standard coverage pathway exists under NCD 354 |
| Low back pain as symptom of metastatic cancer | Not Covered | N/A | Excluded from CLBP definition — does not qualify under NCD 354 |
| Low back pain as manifestation of rheumatoid arthritis | Not Covered | N/A | Systemic disease exclusion — primary disease entity |
| Low back pain as manifestation of multiple sclerosis | Not Covered | N/A | Systemic disease exclusion — primary disease entity |
| TENS applied in home, physician office, or outpatient clinic | Coverage depends on indication | DME benefit category | Setting alone does not determine coverage — CED enrollment is the governing criterion |
CMS TENS Billing Guidelines and Action Items 2026
This policy has real financial exposure. The steps below are not optional if you bill TENS for chronic low back pain to Medicare.
| # | Action Item |
|---|---|
| 1 | Confirm CED enrollment before every TENS claim for CLBP. As of February 11, 2026, this is the only covered pathway. Build a verification checkpoint into your intake or order workflow. If your team can't confirm the patient is enrolled in an approved clinical study, do not bill Medicare for TENS. |
| 2 | Audit your current TENS claims going back 90 days. Pull every claim where TENS was billed for a low back pain diagnosis. Flag any where CED enrollment was not documented. If you find gaps, talk to your compliance officer before doing anything else — this could be a self-disclosure situation depending on volume. |
| 3 | Screen for the CLBP diagnostic exclusions. Before billing, verify that the patient's low back pain is not a symptom of cancer, rheumatoid arthritis, multiple sclerosis, or another recognized primary disease. Document in the chart that the pain meets the NCD 354 CLBP definition — three months or longer, no primary disease entity. |
| 4 | Check your MAC's local coverage determinations. NCD 354 sets the national floor. Your Medicare Administrative Contractor may have more specific billing guidelines or prior authorization requirements for TENS as durable medical equipment. Look up your MAC's LCD before February 11, 2026 and compare it against your current workflow. |
| 5 | Update your DME billing documentation templates. Because TENS reimburses under the DME fee schedule, the documentation requirements include proof of medical necessity, the treating provider's order, and now CED enrollment confirmation. Add a CED enrollment field to your DME order template so the documentation is captured at the point of order. |
| 6 | Educate your ordering providers on the CED-only status. Physicians and mid-levels often don't know this coverage policy exists. If they're ordering TENS for Medicare patients with CLBP without connecting them to an approved clinical trial, those orders are generating non-covered claims. A one-page reference sheet on NCD 354 CED requirements, distributed before February 11, 2026, will cut denials. |
| 7 | Do not bill TENS for CLBP under a non-CLBP diagnosis to work around the CED requirement. This is a compliance risk, not a billing workaround. If the clinical record documents low back pain and the treatment is TENS, the claim will get scrutinized. Diagnosis coding must match the documented condition. |
If your patient population includes significant Medicare volume with chronic low back pain, the exposure here is meaningful. Talk to your compliance officer and billing consultant about your current TENS claim volume before the effective date of February 11, 2026.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for TENS Under NCD 354
This policy does not list specific CPT or HCPCS codes in the NCD 354 policy document. That's not unusual for CMS national coverage determinations — code-level specificity often lives at the MAC level in local coverage determinations.
What This Means for Your Billing Team
The absence of codes in the NCD text means you need to do additional work before February 11, 2026. Your MAC's LCD is the document that will list the specific HCPCS codes for TENS devices and supplies that are covered under the DME benefit. Common TENS-related HCPCS codes appear in MAC-level policies, but the Centers for Medicare & Medicaid Services have not enumerated them at the national level in this NCD.
Contact your MAC directly or pull their LCD for TENS/neurostimulator coverage. Cross-reference those codes against the NCD 354 CED requirements to confirm which codes are covered only under CED and which (if any) have standard coverage pathways for other indications.
Do not guess at codes. Billing the wrong HCPCS code for a TENS device — or billing a code that your MAC only covers for non-CLBP indications — creates a claim denial and a documentation problem. Get the code list from your MAC's LCD, confirm the covered indications match what you're treating, and document accordingly.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.